Leukocyte trafficking in tumor microenvironment.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Current opinion in pharmacology (Print)

• Publication date

  2017-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.coph.2017.05.004PMID 28577499
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dendritic cells in cancer: the role revisited.

  2017cited by this paper
• Tumour-associated macrophages as treatment targets in oncology

  2017cited by this paper
• Role of Distinct Natural Killer Cell Subsets in Anticancer Response

  2017cited by this paper
• Dysregulation of Chemokine/Chemokine Receptor Axes and NK Cell Tissue Localization during Diseases

  2016cited by this paper
• Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards

  2016cited by this paper
• The transcriptome of lung tumor-infiltrating dendritic cells reveals a tumor-supporting phenotype and a microRNA signature with negative impact on clinical outcome

  2016cited by this paper
• B cell regulation of the anti-tumor response and role in carcinogenesis

  2016cited by this paper
• Satb1 Overexpression Drives Tumor-Promoting Activities in Cancer-Associated Dendritic Cells.

  2016cited by this paper
• 24-Hydroxycholesterol participates in pancreatic neuroendocrine tumor development

  2016cited by this paper
• M-CSF and GM-CSF Receptor Signaling Differentially Regulate Monocyte Maturation and Macrophage Polarization in the Tumor Microenvironment.

  2016cited by this paper
• Neutrophils in the Tumor Microenvironment.

  2016cited by this paper
• STK11/LKB1 Deficiency Promotes Neutrophil Recruitment and Proinflammatory Cytokine Production to Suppress T-cell Activity in the Lung Tumor Microenvironment.

  2016cited by this paper
• Hypoxia induces myeloid‐derived suppressor cell recruitment to hepatocellular carcinoma through chemokine (C‐C motif) ligand 26

  2016cited by this paper
• Critical Role for CD103(+)/CD141(+) Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanoma.

  2016cited by this paper
• State-of-the-art of regulatory dendritic cells in cancer.

  2016cited by this paper
• Macrophage Metabolism Controls Tumor Blood Vessel Morphogenesis and Metastasis.

  2016cited by this paper
• Tertiary lymphoid structures, drivers of the anti‐tumor responses in human cancers

  2016cited by this paper
• The Role of Tumor Associated Macrophages in the Tumor Microenvironment: Mechanism and Functions.

  2016cited by this paper
• Pro- and anti-tumour effects of B cells and antibodies in cancer: a comparison of clinical studies and preclinical models

  2016cited by this paper
• Occurrence and significance of tumor‐associated neutrophils in patients with colorectal cancer

  2016cited by this paper
• Expansion and Activation of CD103(+) Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition.

  2016cited by this paper
• Transcriptional Control of Dendritic Cell Development.

  2016cited by this paper
• Regulatory T Cells in the Tumor Microenvironment and Cancer Progression: Role and Therapeutic Targeting

  2016cited by this paper
• IL17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis

  2015cited by this paper
• The biology of innate lymphoid cells

  2015cited by this paper
• MET is required for the recruitment of anti-tumoural neutrophils

  2015cited by this paper
• Targeting YAP-dependent MDSC infiltration impairs tumor progression

  2015cited by this paper
• CXCR2/CXCL5 axis contributes to epithelial-mesenchymal transition of HCC cells through activating PI3K/Akt/GSK-3β/Snail signaling.

  2015cited by this paper
• Microenvironmental regulation of therapeutic response in cancer.

  2015cited by this paper
• Regulatory B cells: origin, phenotype, and function.

  2015cited by this paper
• IL17 Promotes Mammary Tumor Progression by Changing the Behavior of Tumor Cells and Eliciting Tumorigenic Neutrophils Recruitment.

  2015cited by this paper
• CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophages

  2015cited by this paper
• Neutrophils: Between Host Defence, Immune Modulation, and Tissue Injury

  2015cited by this paper
• The Multifaceted Roles Neutrophils Play in the Tumor Microenvironment

  2015cited by this paper
• Orchestration and Prognostic Significance of Immune Checkpoints in the Microenvironment of Primary and Metastatic Renal Cell Cancer

  2015cited by this paper
• Overexpression of chemokine receptor CXCR2 and ligand CXCL7 in liver metastases from colon cancer is correlated to shorter disease-free and overall survival

  2015cited by this paper
• CD40 controls CXCR5-induced recruitment of myeloid-derived suppressor cells to gastric cancer

  2015cited by this paper
• The regulatory role of B cells in autoimmunity, infections and cancer: Perspectives beyond IL10 production

  2015cited by this paper
• CXCL10-induced migration of adoptively transferred human natural killer cells toward solid tumors causes regression of tumor growth in vivo

  2015cited by this paper
• Plasmacytoid dendritic cells, a role in neoplastic prevention and progression

  2015cited by this paper
• International Union of Basic and Clinical Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors

  2014cited by this paper
• A positive feedback loop between mesenchymal-like cancer cells and macrophages is essential to breast cancer metastasis.

  2014cited by this paper
• Regulatory T cells in cancer immunotherapy.

  2014cited by this paper
• The cellular and molecular origin of tumor-associated macrophages

  2014cited by this paper
• CCL2/CCR2-dependent recruitment of functional antigen-presenting cells into tumors upon chemotherapy.

  2014cited by this paper
• Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis.

  2014cited by this paper
• CCL21 Cancer Immunotherapy

  2014cited by this paper
• Yin and yang of tumor inflammation: How innate immune suppressors shape the tumor microenvironments

  2014cited by this paper
• Tumor-associated macrophages: from mechanisms to therapy.

  2014cited by this paper
• Macrophage activation and polarization: nomenclature and experimental guidelines.

  2014cited by this paper
• The multifaceted functions of neutrophils.

  2014cited by this paper
• Enrichment of CD56dimKIR+CD57+ highly cytotoxic NK cells in tumor infiltrated lymph nodes of melanoma patients

  2014cited by this paper
• Dissecting the tumor myeloid compartment reveals rare activating antigen-presenting cells critical for T cell immunity.

  2014cited by this paper
• Defective TGF-β signaling in bone marrow-derived cells prevents hedgehog-induced skin tumors.

  2014cited by this paper
• Functional polarization of tumour-associated macrophages by tumour-derived lactic acid

  2014cited by this paper
• A Think Tank of TINK/TANKs: Tumor-Infiltrating/Tumor-Associated Natural Killer Cells in Tumor Progression and Angiogenesis

  2014cited by this paper
• LXR‐dependent and ‐independent effects of oxysterols on immunity and tumor growth

  2014cited by this paper
• Tracking of intertissue migration reveals the origins of tumor-infiltrating monocytes

  2014cited by this paper
• CSF-1R inhibition alters macrophage polarization and blocks glioma progression

  2013cited by this paper
• Abstract LB-346: The Oxysterol-CXCR2 axis plays a key role in the recruitment of tumor promoting neutrophils.

  2013cited by this paper
• Recruitment of a myeloid cell subset (CD11b/Gr1mid) via CCL2/CCR2 promotes the development of colorectal cancer liver metastasis *

  2013cited by this paper
• Macrophage regulation of tumor responses to anticancer therapies.

  2013cited by this paper
• Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function

  2013cited by this paper
• Interaction between natural killer cells and regulatory T cells: perspectives for immunotherapy

  2013cited by this paper
• Genetic and Environmental Determinants of Human NK Cell Diversity Revealed by Mass Cytometry

  2013cited by this paper
• Neutralizing Tumor-Promoting Chronic Inflammation: A Magic Bullet?

  2013cited by this paper
• History of myeloid-derived suppressor cells

  2013cited by this paper
• In Vivo Processing of CXCL5 (LIX) by Matrix Metalloproteinase (MMP)-2 and MMP-9 Promotes Early Neutrophil Recruitment in IL-1β–Induced Peritonitis

  2013cited by this paper
• T cell regulation of natural killer cells

  2013cited by this paper
• Macrophage plasticity and polarization in tissue repair and remodelling

  2013cited by this paper
• Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells.

  2013cited by this paper
• The immune contexture in human tumours: impact on clinical outcome

  2012cited by this paper
• Natural killer cell distribution and trafficking in human tissues

  2012cited by this paper
• Chemokines and NK cells: Regulators of development, trafficking and functions

  2012cited by this paper
• Neutrophils and granulocytic myeloid-derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncology

  2012cited by this paper
• The chemokine system and cancer

  2012cited by this paper
• Accumulation of CCR4+ CTLA-4hi FOXP3+CD25hi Regulatory T Cells in Colon Adenocarcinomas Correlate to Reduced Activation of Conventional T Cells

  2012cited by this paper
• A novel p38‐MAPK signaling axis modulates neutrophil biology in head and neck cancer

  2012cited by this paper
• Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma

  2012cited by this paper
• Innate or Adaptive Immunity? The Example of Natural Killer Cells

  2011cited by this paper
• Molecular profiling to identify relevant immune resistance mechanisms in the tumor microenvironment.

  2011cited by this paper
• Isotypic neutralizing antibodies against mouse GCP-2/CXCL6 inhibit melanoma growth and metastasis.

  2011cited by this paper
• Characterization of chemokines and adhesion molecules associated with T cell presence in tertiary lymphoid structures in human lung cancer.

  2011cited by this paper
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• Characterization of circulating dendritic cells in melanoma: role of CCR6 in plasmacytoid dendritic cell recruitment to the tumor.

  2010cited by this paper
• Disruption of CCR5-Dependent Homing of Regulatory T Cells Inhibits Tumor Growth in a Murine Model of Pancreatic Cancer1

  2009cited by this paper
• Recruitment and Differentiation of Conventional Dendritic Cell Precursors in Tumors

  2009cited by this paper
• Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN.

  2009cited by this paper
• Sphingosine 1-Phosphate Enhances Fcγ Receptor-Mediated Neutrophil Activation and Recruitment under Flow Conditions1

  2009cited by this paper
• Natural killer cells infiltrating human nonsmall‐cell lung cancer are enriched in CD56brightCD16− cells and display an impaired capability to kill tumor cells

  2008cited by this paper
• Tumor cell apoptosis induces tumor‐specific immunity in a CC chemokine receptor 1‐ and 5‐dependent manner in mice

  2008cited by this paper
• Cancer-related inflammation

  2008cited by this paper
• The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues.

  2007cited by this paper
• Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor

  2007cited by this paper
• Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis

  2006cited by this paper
• CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor–β–dependent manner

  2005cited by this paper
• The high expression of Fractalkine results in a better prognosis for colorectal cancer patients.

  2005cited by this paper
• CXC Chemokine Receptor 3 Expression by Activated CD8+ T cells Is Associated with Survival in Melanoma Patients with Stage III Disease

  2004cited by this paper
• High expression of chemokine gene as a favorable prognostic factor in renal cell carcinoma.

  2004cited by this paper
• Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis.

  2004cited by this paper

• Globulol from Alpinia oxyphylla Miq. Enhances the pharmacological effects of anti-PD-1 drugs in combination by reducing PD-L1 expression in hepatocellular carcinoma.

  2026cites this paper
• Glycoengineering CAR-T cells to overcome galectin-3-mediated immunosuppression.

  2026cites this paper
• TNF-α deficiency underlies NK cell dysfunction in colorectal cancer.

  2026cites this paper
• M1 macrophages enhance breast cancer chemoresistance via JAK-STAT3 signaling.

  2025cites this paper
• Deciphering macrophage heterogeneity and factors driving M2 polarization in lung adenocarcinoma through single-cell RNA sequencing

  2025cites this paper
• A Review of the Impact of Exosomal Non-Coding RNAs on the Development of Malignant Colorectal Tumors

  2025cites this paper
• Breaking the hypoxia barrier: Advances and challenges of hyperbaric oxygen therapy in cancer treatment.

  2025cites this paper
• Ferroptosis Enhances T Lymphocyte Infiltration into Glioblastoma Spheroids

  2025cites this paper
• Impact of stromal maturity and proportion on prognosis and immune landscape in colorectal cancer

  2025cites this paper
• The Role and Therapeutic Potential of ARSB Gene in Tumor Development

  2025cites this paper
• The characteristics of the tumor immune microenvironment in colorectal cancer with different MSI status and current therapeutic strategies

  2025cites this paper
• Inflammation in Penile Squamous Cell Carcinoma: A Comprehensive Review

  2025cites this paper
• A narrative review on tumor microenvironment in malignant tumors

  2025cites this paper
• Decoding tumor angiogenesis: pathways, mechanisms, and future directions in anti-cancer strategies

  2025cites this paper
• Unveiling the Cuproptosis in Colitis and Colitis-Related Carcinogenesis: A Multifaceted Player and Immune Moderator

  2025cites this paper
• CD47-mediated tumor microenvironment remodeling: a central mechanism in immune evasion

  2025cites this paper
• Deciphering the dual role of autophagy in gastric cancer and gastroesophageal junction cancer: from tumor suppression to cancer progression

  2025cites this paper
• Nanoparticles for Cancer Immunotherapy: Innovations and Challenges

  2025cites this paper
• Advances in tumor microenvironment: Applications and challenges of 3D bioprinting.

  2024cites this paper
• The significant role of amino acid metabolic reprogramming in cancer

  2024cites this paper
• Cuproptosis, the novel type of oxidation-induced cell death in thoracic cancers: can it enhance the success of immunotherapy?

  2024cites this paper
• Identification of tumor microenvironment-related prognostic biomarkers for ovarian tumor disease-free survival

  2024cites this paper
• Methionine enkephalin (MENK) protected macrophages from ferroptosis by downregulating HMOX1 and ferritin

  2024cites this paper
• Research Status of Tumor Microenvironment in Diffuse Large B-Cell Lymphoma

  2024cites this paper
• Clinical advances in analytical profiling of signature lipids: implications for severe non-communicable and neurodegenerative diseases

  2024cites this paper
• The role of the microenvironment in tumor growth and spreading

  2024cites this paper
• The prognostic biomarker TPGS2 is correlated with immune infiltrates in pan-cancer: a bioinformatics analysis

  2024cites this paper
• Role of Extracellular Vesicles in Castration-Resistant Prostate Cancer.

  2024cites this paper
• Advances in the Study of the Relationship between Fibulin-5 and Tumours

  2024cites this paper
• Endothelial cell Notch signaling programs cancer-associated fibroblasts to promote tumor immune evasion

  2024cites this paper
• Investigation of tumour environments through advancements in microtechnology and nanotechnology.

  2024cites this paper
• Using Combination therapy to overcome diverse challenges of Immune Checkpoint Inhibitors treatment

  2024cites this paper
• How Oxidative Stress Modifies the Immune Response Landscape in Cancer

  2024cites this paper
• Wnt Signaling in Hepatocellular Carcinoma: Biological Mechanisms and Therapeutic Opportunities

  2024cites this paper
• Unraveling molecular interconnections and identifying potential therapeutic targets of significance in obesity-cancer link

  2024cites this paper
• Tumor microenvironment in primary central nervous system lymphoma (PCNSL)

  2024cites this paper
• CTC-neutrophil interaction: A key driver and therapeutic target of cancer metastasis.

  2024cites this paper
• The interaction between m6A modification and noncoding RNA in tumor microenvironment on cancer progression.

  2024cites this paper
• 3D bioprinting tumor models mimic the tumor microenvironment for drug screening.

  2023cites this paper
• SEVs-mediated miR-6750 transfer inhibits pre-metastatic niche formation in nasopharyngeal carcinoma by targeting M6PR

  2023cites this paper
• Integrating single-cell RNA-seq and spatial transcriptomics reveals MDK-NCL dependent immunosuppressive environment in endometrial carcinoma

  2023cites this paper
• An Angiogenesis-Related lncRNA Signature Is Associated with Prognosis and Tumor Immune Microenvironment in Breast Cancer

  2023cites this paper
• Drug-Resistance Mechanism and New Targeted Drugs and Treatments of Relapse and Refractory DLBCL

  2023cites this paper
• The promise of targeting heme and mitochondrial respiration in normalizing tumor microenvironment and potentiating immunotherapy

  2023cites this paper
• Lactic acid: a narrative review of a promoter of the liver cancer microenvironment

  2023cites this paper
• The Prognosis of Cancer Depends on the Interplay of Autophagy, Apoptosis, and Anoikis within the Tumor Microenvironment

  2023cites this paper
• Microenvironmental regulation in tumor progression: Interactions between cancer-associated fibroblasts and immune cells.

  2023cites this paper
• A pan-cancer analysis of pituitary tumor-transforming 3, pseudogene.

  2023cites this paper
• Azurocidin 1 inhibits the aberrant proliferation of triple‑negative breast cancer through the regulation of pyroptosis

  2023cites this paper
• Alternative splicing events and function in the tumor microenvironment: New opportunities and challenges.

  2023cites this paper
• The Relationship Between Lymphocyte Subtypes with Clinicopathological Features and Prognosis of Prostate Cancer in Patients Undergoing Radical Prostatectomy

  2023cites this paper
• Tumor-on-a-chip model for advancement of anti-cancer nano drug delivery system

  2022cites this paper
• Red Blood Cells Protein Profile Is Modified in Breast Cancer Patients

  2022cites this paper
• Hepatocellular Carcinoma Differentiation: Research Progress in Mechanism and Treatment

  2022cites this paper
• The expression of VISTA on CD4+ T cells is associated with poor prognosis and immune status in non-small cell lung cancer patients

  2022cites this paper
• Comprehensive Analysis of the PROSER2-AS1-Related ceRNA Network and Immune Cell Infiltration in Papillary Thyroid Carcinoma

  2022cites this paper
• Notch signaling in tumor vasculature programs cancer-associated fibroblasts to suppress anti-tumor immunity

  2022cites this paper
• From Tumor Cells to Endothelium and Gut Microbiome: A Complex Interaction Favoring the Metastasis Cascade

  2022cites this paper
• Exosome-Derived Non-Coding RNAs in the Tumor Microenvironment of Colorectal Cancer: Possible Functions, Mechanisms and Clinical Applications

  2022cites this paper
• The role of autophagy in initiation, progression, TME modification, diagnosis, and treatment of esophageal cancers.

  2022cites this paper
• Pan-Cancer Characterization of Intratumoral Autonomic Innervation in 32 Cancer Types in the Cancer Genome Atlas

  2022cites this paper
• Extracellular‐Vesicle‐Based Drug Delivery Systems for Enhanced Antitumor Therapies through Modulating the Cancer‐Immunity Cycle

  2022cites this paper
• A Systematic Pan-Cancer Analysis of YY1 Aberrations and their Relationship with Clinical Outcome, Tumor Microenvironment, and Therapeutic Targets

  2022cites this paper
• Tumor Microenvironment Characterization in Breast Cancer and an Immune Cell Infiltration Score Development, Validation, and Application

  2022cites this paper
• Advances, challenge and prospects in cell-mediated nanodrug delivery for cancer therapy: a review

  2022cites this paper
• GRHL2 Expression Functions in Breast Cancer Aggressiveness and Could Serve as Prognostic and Diagnostic Biomarker for Breast Cancer

  2022cites this paper
• Immune Checkpoint Inhibitors in Cancer Therapy—How to Overcome Drug Resistance?

  2022cites this paper
• Modulation of diverse oncogenic signaling pathways by oroxylin A: An important strategy for both cancer prevention and treatment.

  2022cites this paper
• Urological cancer organoids, patients' avatars for precision medicine: past, present and future

  2022cites this paper
• FABP6 Expression Correlates with Immune Infiltration and Immunogenicity in Colorectal Cancer Cells

  2022cites this paper
• Surface Membrane Coating as a Versatile Platform for Modifying Antitumor Nanoparticles

  2022cites this paper
• Short-chain L-3-hydroxyacyl-CoA dehydrogenase: A novel vital oncogene or tumor suppressor gene in cancers

  2022cites this paper
• Journal Pre-proof Red blood cells protein profile is modified in breast cancer patients

  2022cites this paper
• Cuprotosis Programmed-Cell-Death-Related lncRNA Signature Predicts Prognosis and Immune Landscape in PAAD Patients

  2022cites this paper
• Analysis of the key ligand receptor CADM1_CADM1 in the regulation of thyroid cancer based on scRNA-seq and bulk RNA-seq data

  2022cites this paper
• Targeting hypoxia-inducible factors for breast cancer therapy: A narrative review

  2022cites this paper
• Drug Resistance: The Role of Exosomal miRNA in the Microenvironment of Hematopoietic Tumors

  2022cites this paper
• Inflammation-Driven Breast Tumor Cell Plasticity: Stemness/EMT, Therapy Resistance and Dormancy

  2021cites this paper
• Targeting the MDSCs of Tumors In Situ With Inhibitors of the MAPK Signaling Pathway to Promote Tumor Regression

  2021cites this paper
• Interleukin-34-CSF1R Signaling Axis Promotes Epithelial Cell Transformation and Breast Tumorigenesis

  2021cites this paper
• Crosstalk between Macrophages, T Cells, and Iron Metabolism in Tumor Microenvironment

  2021cites this paper
• Structural Biology of the Tumor Microenvironment.

  2021cites this paper
• Basics of immunotherapy for epithelial ovarian cancer.

  2021cites this paper
• Identification of prognostic biomarkers associated with tumor microenvironment in ceRNA network for esophageal squamous cell carcinoma: a bioinformatics study based on TCGA database

  2021cites this paper
• Mesenchymal stem cells in cancer therapy; the art of harnessing a foe to a friend

  2021cites this paper
• Insights on neuroendocrine regulation of immune mediators in female reproductive aging and cancer

  2021cites this paper
• Caveolin1: its roles in normal and cancer stem cells

  2021cites this paper
• Differences in Immunological Landscape between EGFR-Mutated and Wild-Type Lung Adenocarcinoma

  2021cites this paper
• Establishment of Three-Dimensional Bioprinted Bladder Cancer-on-a-Chip with a Microfluidic System Using Bacillus Calmette–Guérin

  2021cites this paper
• Potential Strategies to Improve the Effectiveness of Drug Therapy by Changing Factors Related to Tumor Microenvironment

  2021cites this paper
• Angiogenic Properties of NK Cells in Cancer and Other Angiogenesis-Dependent Diseases

  2021cites this paper
• Construction of a DLBCL Prognostic Signature Based on Tumor Microenvironment

  2021cites this paper
• Continuous Inflammatory Stimulation Leads via Metabolic Plasticity to a Prometastatic Phenotype in Triple-Negative Breast Cancer Cells

  2021cites this paper
• The Role of V-Domain Ig Suppressor of T Cell Activation (VISTA) in Cancer Therapy: Lessons Learned and the Road Ahead

  2021cites this paper
• The Tumour Vasculature as a Target to Modulate Leucocyte Trafficking

  2021cites this paper
• Persistent Inflammatory Stimulation Drives the Conversion of MSCs to Inflammatory CAFs That Promote Pro-Metastatic Characteristics in Breast Cancer Cells

  2021cites this paper
• Tumor microenvironment and future targets of immunotherapy in breast cancer

  2020influential citation
• Beyond Cell Motility: The Expanding Roles of Chemokines and Their Receptors in Malignancy

  2020cites this paper
• Correlation between prognostic indicator AHNAK2 and immune infiltrates in lung adenocarcinoma.

  2020cites this paper
• Comparison between clinical significance of serum CXCL-8 and classical tumor markers in oesophageal cancer (OC) patients

  2019cites this paper